Literature DB >> 18429040

System identification theory in pharmacokinetic modeling of dynamic contrast-enhanced MRI: influence of contrast injection.

H J W L Aerts1, N A W van Riel, W H Backes.   

Abstract

Optimization of experimental settings of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), like the contrast administration protocol, is of great importance for reliable quantification of the microcirculatory properties, such as the volume transfer-constant K(trans). Using system identification theory and computer simulations, the confounding effects of volume, rate and multiplicity of a contrast injection on the reliability of K(trans) estimation was assessed. A new tracer-distribution model (TDM), based on in vivo data from rectal cancer patients, served to describe the relationship between the contrast agent injection and the blood time-course. A pharmacokinetic model (PKM) was used to describe the relation between the blood and tumor tissue time-courses. By means of TDM and PKM in series, the tissue-transfer function of the PKM was analyzed. As both the TDM and PKM represented low-frequency-pass filters, the energy-density at low frequencies of the blood and tissue time-courses was larger than at high frequencies. The simulations, based on measurements in humans, predict that the K(trans) is most reliable with a high injection volume administered in a single injection, where high rates only modestly improve K(trans). (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18429040     DOI: 10.1002/mrm.21575

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  10 in total

1.  Precision analysis of kinetic modelling estimates in dynamic contrast enhanced MRI.

Authors:  Dieter De Naeyer; Yves De Deene; Wim P Ceelen; Patrick Segers; Pascal Verdonck
Journal:  MAGMA       Date:  2011-01-08       Impact factor: 2.310

2.  Fast, reproducible measurement of the vascular input function in mice using constrained reconstruction and cardiac sampling.

Authors:  Dustin K Ragan; Stephen Y Lai; James A Bankson
Journal:  NMR Biomed       Date:  2010-09-22       Impact factor: 4.044

3.  The influence of temporal resolution in determining pharmacokinetic parameters from DCE-MRI data.

Authors:  Marieke Heisen; Xiaobing Fan; Johannes Buurman; Natal A W van Riel; Gregory S Karczmar; Bart M ter Haar Romeny
Journal:  Magn Reson Med       Date:  2010-03       Impact factor: 4.668

4.  Pharmacokinetic mapping for lesion classification in dynamic breast MRI.

Authors:  Matthias C Schabel; Glen R Morrell; Karen Y Oh; Cheryl A Walczak; R Brad Barlow; Leigh A Neumayer
Journal:  J Magn Reson Imaging       Date:  2010-06       Impact factor: 4.813

5.  Dynamic contrast-enhanced MRI perfusion quantification in hepatocellular carcinoma: comparison of gadoxetate disodium and gadobenate dimeglumine.

Authors:  Daniel Stocker; Stefanie Hectors; Octavia Bane; Naik Vietti-Violi; Daniela Said; Paul Kennedy; Jordan Cuevas; Guilherme M Cunha; Claude B Sirlin; Kathryn J Fowler; Sara Lewis; Bachir Taouli
Journal:  Eur Radiol       Date:  2021-05-27       Impact factor: 5.315

6.  A dedicated automated injection system for dynamic contrast-enhanced MRI experiments in mice.

Authors:  Jan Sedlacik; Adrianne Myers; Ralf B Loeffler; Regan F Williams; Andrew M Davidoff; Claudia M Hillenbrand
Journal:  J Magn Reson Imaging       Date:  2012-09-21       Impact factor: 4.813

7.  Towards endometriosis diagnosis by gadofosveset-trisodium enhanced magnetic resonance imaging.

Authors:  Marc H Schreinemacher; Walter H Backes; Jos M Slenter; Sofia Xanthoulea; Bert Delvoux; Larissa van Winden; Regina G Beets-Tan; Johannes L H Evers; Gerard A J Dunselman; Andrea Romano
Journal:  PLoS One       Date:  2012-03-22       Impact factor: 3.240

Review 8.  Dynamic Contrast-Enhanced MRI to Study Atherosclerotic Plaque Microvasculature.

Authors:  Raf H M van Hoof; Sylvia Heeneman; Joachim E Wildberger; M Eline Kooi
Journal:  Curr Atheroscler Rep       Date:  2016-06       Impact factor: 5.113

9.  Impact of contrast agent injection duration on dynamic contrast-enhanced MRI quantification in prostate cancer.

Authors:  Edzo M E Klawer; Petra J van Houdt; Floris J Pos; Stijn W T P J Heijmink; Matthias J P van Osch; Uulke A van der Heide
Journal:  NMR Biomed       Date:  2018-07-05       Impact factor: 4.044

10.  Suitability of pharmacokinetic models for dynamic contrast-enhanced MRI of abdominal aortic aneurysm vessel wall: a comparison.

Authors:  V Lai Nguyen; M Eline Kooi; Walter H Backes; Raf H M van Hoof; Anne E C M Saris; Mirthe C J Wishaupt; Femke A M V I Hellenthal; Rob J van der Geest; Alfons G H Kessels; Geert Willem H Schurink; Tim Leiner
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.